Tempus is a leading technology company at the forefront of precision medicine, utilizing artificial intelligence (AI) and extensive data analysis to revolutionize healthcare. The company's core mission is to empower physicians, researchers, and pharmaceutical companies with data-driven insights to personalize patient care and accelerate therapeutic development.
Tempus achieves this by collecting and analyzing vast amounts of clinical and molecular data, including genomic sequencing, real-world data, and pathology images. They offer a suite of AI-powered diagnostic tests across various therapeutic areas, with a strong focus on oncology, but also expanding into psychiatry, infectious disease, cardiology, and neurology. Their proprietary platform, including devices like Tempus One and a comprehensive data portal, provides actionable intelligence to guide treatment decisions and research.
In essence, Tempus combines advanced AI algorithms, a massive dataset of clinical and molecular information, and human expertise to make precision medicine a reality, facilitating more targeted and effective treatments.